Drug Target Review

JULY 4, 2023

Over the last two decades, an increasing number of Antibody Drug Conjugate (ADC) therapeutics have been approved for oncology indications. These therapies have broadened treatment options for patients to expand beyond the more traditional small molecule drug alternatives. 3D rendering of Antibody Drug Conjugate Molecules.

Small Molecule 145

Small Molecule Drugs Clinical Pharmacology Trials 145

The Pharma Data

NOVEMBER 8, 2020

This transaction will enhance Pharmaron’s fully integrated, end-to-end drug R&D service offerings globally. Absorption Systems is based in the USA with facilities and laboratories in Philadelphia, San Diego and Boston. Pharmaron is a publicly owned, premier R&D service provider for the life sciences industry.

Clinical Pharmacology 40

Clinical Pharmacology Laboratories Science Pharmaceuticals 40

Alta Sciences

MAY 15, 2023

TOP 5 WAYS INTEGRATED DRUG DEVELOPMENT SOLUTIONS SAVE YOU TIME AND MONEY aasimakopoulos Mon, 05/15/2023 - 16:06 Since 2004, the average cost of bringing a new drug to market has increased from $800 million to about $2.6 Here are five ways an integrated drug development solution can simplify and accelerate your programs: 1.

Drug Development 52

Drug Development Clinical Trials Laboratories Compounding Pharmacies 52

Agency IQ

FEBRUARY 12, 2024

A closer look at CDER’s new 2024 guidance agenda The FDA’s Center for Drug Evaluation and Research, its drug review division, this week quietly updated its 2024 Guidance Agenda, a list of all draft guidance documents the agency is working on this calendar year.

Biosimilars 40

Biosimilars Science Clinical Pharmacology FDA 40